Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model

被引:43
作者
Li, X
Brasseur, P
Agnamey, P
Leméteil, D
Favennec, L
Ballet, JJ [1 ]
Rossignol, JF
机构
[1] CHU Clemenceau, Lab Immunol & Immunopathol, F-14033 Caen, France
[2] Fac Med Pharm, Parasitol Lab, F-76138 Rouen, France
[3] ADEN, UPRES EA 3234, F-76138 Rouen, France
[4] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England
关键词
Cryptosporidium parvum; nitazoxanide; immunosuppressed rat model;
D O I
10.14411/fp.2003.003
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Cryptosporidium parvum, Tyzzer, 1912 is identified as a common cause of diarrhoea in immunocompetent individuals. In immunocompromised, especially HIV-infected subjects, cryptosporidiosis causes severe chronic diarrhoea. In this study, nitazoxanide (NTZ) was compared for curative activity with sinefungin (SNF) and paromomycin (PRM) in immunosuppressed rats, a screening model for anticryptosporidial agents. NTZ at either 50 mg/kg/day, 100 mg/kg/day or 200 mg/kg/day resulted in seven days in a dose-dependent inhibition of oocyst shedding similar to that obtained with SNF (10 mg/kg/day) and PRM (100 mg/kg/day). Further discontinuation of SNF or PRM 100 mg/kg/day therapy resulted in early relapse of oocyst shedding which reached the pre-treatment levels in 2-4 days. In contrast, seven days after discontinuation of therapy, shedding inhibition was unchanged in NTZ-treated rats. Data prompt further assessment of the activity of NTZ on sequestered C. parvum.
引用
收藏
页码:19 / 22
页数:4
相关论文
共 23 条
[1]   Successful treatment with nitazoxanide of Enterocytozoon bieneusi microsporidiosis in a patient with AIDS [J].
Bicart-Sée, A ;
Massip, P ;
Linas, MD ;
Datry, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (01) :167-168
[2]   Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model [J].
Blagburn, BL ;
Drain, KL ;
Land, TM ;
Kinard, RG ;
Moore, PH ;
Lindsay, DS ;
Patrick, DA ;
Boykin, DW ;
Tidwell, RR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) :2877-2882
[3]  
BLAGBURN BL, 1997, CRYPTOSPORIDIUM CRYP, P111
[4]   RAT MODEL FOR HUMAN CRYPTOSPORIDIOSIS [J].
BRASSEUR, P ;
LEMETEIL, D ;
BALLET, JJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (05) :1037-1039
[5]  
BRASSEUR P, 1994, FOLIA PARASIT, V41, P13
[6]  
Davies L, 2000, POETRY WALES, V36, P50
[7]   Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa [J].
Doumbo, O ;
Rossignol, JF ;
Pichard, E ;
Traore, HA ;
Dembele, M ;
Diakite, M ;
Traore, F ;
Diallo, DA .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1997, 56 (06) :637-639
[8]  
DUBREUIL L, 1996, ANTIMICROB AGENTS CH, V40, P2260
[9]   Human cryptosporidiosis: Epidemiology, transmission, clinical disease, treatment, and diagnosis [J].
Griffiths, JK .
ADVANCES IN PARASITOLOGY - OPPORTUNISTIC PROTOZOA IN HUMANS, 1998, 40 :37-85
[10]   THERAPEUTIC EFFICACY OF PAROMOMYCIN IN IMMUNOSUPPRESSED ADULT MICE INFECTED WITH CRYPTOSPORIDIUM-PARVUM [J].
HEALEY, MC ;
YANG, SG ;
RASMUSSEN, KR ;
JACKSON, MK ;
DU, CW .
JOURNAL OF PARASITOLOGY, 1995, 81 (01) :114-116